TCL Archive Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less August 2, 1985
TCL Archive Death On Saltz Regimen Prompt Groups To Suspend Accrual On Colon Cancer Trials. May 11, 2001